Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP)
Canada Communicable Disease Report · 12.11.2026 · 52 (11) · 435-439
DOI: 10.14745/ccdr.v52i11a01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canada Communicable Disease Report, online erschienen am 12.11.2026. Verfasst von April Killikelly und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Killikelly, A., Warshawky, B., & O'Driscoll, M. (2026). Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP). Canada Communicable Disease Report, 52(11), 435-439. https://doi.org/10.14745/ccdr.v52i11a01
Vancouver
Killikelly A, Warshawky B, O'Driscoll M. Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP). Canada Communicable Disease Report. 2026;52(11):435-439. doi:10.14745/ccdr.v52i11a01
BibTeX
@article{Killikelly2026,
author = {Killikelly, April and Warshawky, Bryna and O'Driscoll, Miranda},
title = {Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP)},
journal = {Canada Communicable Disease Report},
year = {2026},
volume = {52},
number = {11},
pages = {435--439},
doi = {10.14745/ccdr.v52i11a01}
}
EUVIMED